Stock BIIB BIOGEN INC.
Add to a list
To use this feature you must be a member
Log inSign up

Revisions Biogen Inc.

Equities

BIIB

US09062X1037

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-26 pm EDT 		5-day change 1st Jan Change
208.9 USD +3.18% Intraday chart for Biogen Inc. +7.47% -19.27%
Apr. 26 Guggenheim Adjusts Price Target on Biogen to $255 From $275 MT
Apr. 25 Biogen Inc. Receives Positive CHMP Opinion for TOFIDence (tocilizumab), a Biosimilar Referencing ROACTEMRA CI

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Dividend / Share (DPS) - Change in analysts' estimates

Cash or Net Debt - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

Dividend / Share (DPS)

Cash or Net Debt

  1. Stock Market
  2. Equities
  3. BIIB Stock
  4. Revisions Biogen Inc.